--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q235.000M / 1.000M--
--2024/Q10.000 / 0.000--
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
ITOS ITeos Therapeutics
- 7.420
- +0.200+2.77%
Close Dec 20 16:00 ET
- 7.450
- +0.030+0.41%
Post 19:29 ET
271.08MMarket Cap-2.36P/E (TTM)
7.510High7.090Low2.44MVolume7.170Open7.220Pre Close17.96MTurnover8.68%Turnover RatioLossP/E (Static)36.53MShares18.75052wk High0.43P/B208.84MFloat Cap7.09052wk Low--Dividend TTM28.15MShs Float52.430Historical High--Div YieldTTM5.82%Amplitude7.090Historical Low7.346Avg Price1Lot Size
ITeos Therapeutics Key Stats
ITeos Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
ITeos Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data